IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine

IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine

Background: Interleukin (IL)17A is a member of the IL17 cytokine family, which is released by both immune and non-immune cells such as tumor and stromal cells into the tumor microenvironment. IL17 receptors are also widely expressed in different type of cells. Among all the members, IL17A is the mos...

Full description

Bibliographic Details
Main Authors: Cecilia Roux, Gianluca Mucciolo, Joanna Kopecka, Francesco Novelli, Chiara Riganti, Paola Cappello
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Antioxidants
Subjects:
Interleukin 17A (IL17A)
macrophages
metabolism
pancreatic cancer
chemo-immunotherapy
Online Access:https://www.mdpi.com/2076-3921/10/3/422

Internet

https://www.mdpi.com/2076-3921/10/3/422

Similar Items